Prostate adenocarcinoma is present in over 80% of men over the age of 80 and is by far the most common cancer of men. Although radical prostatectomy is cur...vekri
Prostate cancer affects mainly older men. About 80% of cases are in men over 65, and less than 1% of cases are in men under 50. African American men and those with a family history of prostate cancer are more likely to get it. Doctors don’t know what causes prostate cancer, but die...
Prostate cancer is the second-most common cancer in the U.S., exceeded only bybreast cancer. About one-eighth of U.S. men are diagnosed withprostate cancerat a median age of 67, according to the National Cancer Institute. Most patients have slow-growing, localized tumors, confined to thep...
The UK NSC recommendation on prostate cancer screening/PSA testing in men over the age of 50. https://legacyscreening.phe.org.uk/prostatecancer. Accessed February 9, 2018. 8. Tsodikov A, Gulati R, Heijnsdijk EAM, et al. Reconciling the effects of screening on prostate cancer ...
Despite the widespread use of prostate specific antigen for early prostate cancer (PCa) detection in younger men, PCa is still as disease of the elderly as 2/3 of incident cases are detected in men older than 65 years and 25% are older than 75 years at diagnosis. Opportunistic screening fo...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of th
prostate cancer. This study used the provincial cancer registry in British Columbia, Canada, to determine median non-prostate cancer survival for men who were aged 75 to 82 years at start of radiation treatment. Median survival was found to be greater than 10 years in men aged up to 80 ...
prostate cancer is common, with many older men showing localized prostate tumors upon autopsy that died from other causes[1]. In contrast, oncemetastasishas been detected by imaging, the vast majority of patients will likely die from prostate cancer. Over the past two decades, serum PSA ...
Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. We assess whether the Gleason grade changes in men followed expectantly with clinical stage T1c prostate cancer. We studied 70 men with stage T1c prostate ... JI Epstein,PC Walsh,H Ballantine...
THERE has been much said about screening men for prostate cancer but still nothing has been done and men in the UK are dying at the rate of 10,000 a year - one man every hour. Most men show no symptoms of the disease, but when they do it is already too late. If we do not s...